Brucella

Introduction

  • Brucella is a genus of Gram-negative, facultative intracellular coccobacilli.

  • Brucella species are the causative agents of brucellosis, also known as undulant fever, Malta fever, or Mediterranean fever.

  • Brucellosis is a major zoonotic disease, transmitted from animals to humans.

  • Humans acquire infection through:

    • Consumption of unpasteurized milk and dairy products

    • Direct contact with infected animals or animal products

    • Inhalation of infectious aerosols (laboratory exposure)

  • Common pathogenic species include:

    • Brucella melitensis

    • Brucella abortus

    • Brucella suis

    • Brucella canis

  • Brucella organisms have the ability to survive and multiply within macrophages, contributing to chronic infection.

  • The disease affects multiple systems, particularly:

    • Musculoskeletal

    • Reticuloendothelial

    • Genitourinary

    • Nervous system

  • Laboratory diagnosis relies on:

    • Culture

    • Serological tests

    • Molecular methods

  • Brucellosis is an important occupational hazard for veterinarians, farmers, abattoir workers, and laboratory personnel.

  • Control strategies focus on animal vaccination, food safety, surveillance, and public health education.

 


General Character


Genus: Brucella

Family

  • Brucellaceae

Species and Primary Hosts

  1. Brucella abortus

    • Primarily affects cattle

    • Causes abortion in animals and brucellosis in humans

  2. Brucella melitensis

    • Primarily affects goats and sheep

    • Most virulent species for humans

    • Common cause of severe human brucellosis

  3. Brucella suis

    • Primarily affects pigs

    • Associated with chronic and suppurative infections in humans

  4. Brucella canis

    • Affects dogs

    • Causes relatively milder disease in humans


Morphology and Staining Characteristics

Gram Staining

  • Gram-negative bacteria

  • Appear pink due to:

    • Thin peptidoglycan layer

    • Presence of outer membrane with LPS

Shape

  • Small coccobacilli

  • Short, plump rod-shaped organisms

Arrangement

  • Occur:

    • Singly

    • In small clusters

  • Do not form chains


Oxygen Requirements 

  • Obligate aerobes

  • Some strains (especially B. abortus) require 5–10% CO₂ for primary isolation

 Key concept:

  • Brucella species are facultative intracellular organisms,
    NOT facultative anaerobes

 


Morphology


1. Size

  • Very small bacteria

  • Measure approximately 0.5–0.7 µm × 0.6–1.5 µm

2. Shape

  • Coccobacilli

  • Short, plump rod-shaped organisms

  • Appear intermediate between cocci and bacilli

3. Gram Reaction

  • Gram-negative

  • Appear pink on Gram staining due to:

    • Thin peptidoglycan layer

    • Presence of outer membrane with LPS

  • Often poorly stained with routine Gram stain

4. Arrangement

  • Occur:

    • Singly

    • Occasionally in small clusters

  • Do not form chains or palisades

5. Motility

  • Non-motile

  • Lack flagella

6. Capsule

  • Non-capsulated

  • No true polysaccharide capsule

7. Spores

  • Non-sporing

8. Pleomorphism

  • Minimal pleomorphism

  • Fairly uniform morphology

9. Special Staining Characteristics

  • Weakly acid-fast

  • Demonstrated by:

    • Modified Ziehl–Neelsen stain (1% sulfuric acid)

  • Stamp’s modification:

    • Organisms stain red against a blue background

    • Commonly used in veterinary microbiology

 


Cultural Characteristics


Growth Requirements

  • Fastidious, slow-growing organisms

  • Obligate aerobes

  • Optimal temperature: 35–37 °C

  • Optimal pH: 6.6–7.4

  • Some strains (especially B. abortus) require 5–10% CO₂ for primary isolation

  • Visible growth usually appears after 3–7 days, may take up to 2–3 weeks


Culture Media Used

A. Blood Agar

  • Enriched medium

  • Supports growth of most Brucella species

  • Colonies appear after 48–72 hours or later

B. Chocolate Agar

  • Better recovery than blood agar

  • Commonly used for routine isolation

C. Brucella Agar (Selective Medium)

  • Enriched with:

    • Blood or serum

    • Vitamins

  • Selective agents:

    • Polymyxin B

    • Bacitracin

    • Nystatin

    • Vancomycin

  • Used for specimens with mixed flora

D. Castaneda Biphasic Medium

  • Contains:

    • Solid agar phase + liquid broth phase

  • Medium of choice for blood culture

  • Minimizes risk of laboratory contamination and aerosol exposure


Colony Morphology

On Blood / Chocolate Agar

  • Small (1–2 mm), round, smooth, convex colonies

  • Translucent, glistening

  • Non-hemolytic

  • Honey-drop / dew-drop” appearance


Colony Types (Antigenic Phases)

Colony Type Species Characteristics
Smooth (S) B. abortus, B. melitensis, B. suis Smooth LPS, virulent
Rough (R) B. canis Rough LPS, less virulent

Growth on Other Media

  • MacConkey agar:

    • Usually no growth

    • If growth occurs → non-lactose fermenting colonies

  • Low nutrient media: Poor or no growth

 


Biochemical Reactions


A. Oxidase Test

  • Positive in all Brucella species

B. Catalase Test

  • Positive in all species

  • Helps survival within macrophages by neutralizing hydrogen peroxide

C. Urease Test 

  • Strongly positive

  • Rapid urease activity (within minutes to a few hours)

  • One of the most characteristic features of Brucella

D. Nitrate Reduction Test

  • Positive in most Brucella species

  • Helps in differentiation from other Gram-negative coccobacilli

E. Indole Test

  • Negative

F. Citrate Utilization

  • Negative

G. Hydrogen Sulfide (H₂S) Production 

Species H₂S Production
B. abortus Positive
B. suis Positive
B. melitensis Negative
B. canis Negative

 


Pathogenicity


Source of Infection

  • Infected animals:

    • Cattle (B. abortus)

    • Goats & sheep (B. melitensis)

    • Pigs (B. suis)

    • Dogs (B. canis)

  • Animal products:

    • Unpasteurized milk, cheese

    • Meat, placenta, aborted fetuses


Mode of Transmission

  • Ingestion: Unpasteurized dairy products (most common)

  • Direct contact: Through skin abrasions or mucous membranes

  • Inhalation: Aerosols (laboratory-acquired infection)

  • Rarely: Vertical transmission, blood transfusion


Portal of Entry

  • Gastrointestinal tract

  • Respiratory tract

  • Skin and conjunctiva


Virulence Factors

(Brucella lacks classic exotoxins)

A. Intracellular Survival Mechanisms 

  • Smooth LPS:

    • Poorly endotoxic

    • Inhibits phagolysosome fusion

  • Type IV secretion system (VirB)

    • Enables intracellular replication

  • Superoxide dismutase & catalase

    • Protect against oxidative killing

  • Urease

    • Aids survival in acidic environments


Pathogenesis 

  1. Entry into the host via ingestion, inhalation, or contact

  2. Phagocytosis by macrophages and dendritic cells

  3. Survival and multiplication within phagosomes

  4. Spread via lymphatics and bloodstream

  5. Localization in reticuloendothelial organs:

    • Liver

    • Spleen

    • Bone marrow

    • Lymph nodes

  6. Formation of granulomas

  7. Persistence leads to chronic infection


Host Immune Response

  • Cell-mediated immunity is crucial

  • Th1 response (IFN-γ) activates macrophages

  • Antibodies:

    • Useful for diagnosis

    • Limited role in protection

 


Laboratory Diagnosis


Specimen Collection 

A. Common Specimens

  • Blood (most important)

  • Bone marrow (highest yield)

  • CSF (neurobrucellosis)

  • Synovial fluid

  • Tissue biopsy (lymph node, liver)

B. Safety Note

  • Highly infectious organism

  • All specimens handled with BSL-3 precautions


Direct Microscopy

  • Gram stain:

    • Small Gram-negative coccobacilli

    • Low sensitivity

  • Not reliable for routine diagnosis


Culture Methods

A. Blood Culture

  • Castaneda biphasic medium – medium of choice

  • Incubation:

    • 35–37 °C

    • Aerobic

    • With 5–10% CO₂ (especially B. abortus)

  • Duration:

    • Up to 4–6 weeks

  • Subcultures done weekly

B. Bone Marrow Culture

  • Most sensitive culture method

  • Useful in:

    • Chronic cases

    • Prior antibiotic therapy


Automated Blood Culture Systems

  • BACTEC / BacT-ALERT

  • Faster detection (within 5–7 days)

  • Improved sensitivity and safety


Identification of Isolates

  • Colony morphology on blood/chocolate agar

  • Biochemical tests:

    • Oxidase positive

    • Catalase positive

    • Rapid urease positive

  • H₂S production and dye sensitivity (reference labs)


Serological Tests

A. Standard Agglutination Test 

  • Detects anti-Brucella antibodies

  • Diagnostic titer:

    • ≥1:160 (single sample)

    • Fourfold rise in paired sera

  • Limitation:

    • Cannot differentiate acute vs chronic

    • Prozone phenomenon


B. Rose Bengal Plate Test (RBPT)

  • Rapid screening test

  • High sensitivity

  • Used for:

    • Mass screening

    • Field surveys


C. 2-Mercaptoethanol (2-ME) Test

  • Detects IgG antibodies

  • Helps distinguish:

    • Active vs chronic infection

    • Past exposure


D. ELISA

  • Detects IgM, IgG, IgA

  • High sensitivity and specificity

  • Useful in:

    • Early diagnosis

    • Chronic and complicated cases


Molecular Methods

PCR

  • Detects Brucella DNA

  • Highly sensitive and specific

  • Useful in:

    • Early disease

    • Relapse

    • Culture-negative cases


Hematological Findings

  • Anemia

  • Leukopenia or leukocytosis

  • Raised ESR

  • Mild thrombocytopenia

 


Antibiotic Resistance


Natural Susceptibility Pattern

  • Generally susceptible to:

    • Tetracyclines (Doxycycline)

    • Rifampicin

    • Aminoglycosides (Streptomycin, Gentamicin)

    • Fluoroquinolones

    • TMP–SMX


Intrinsic Resistance

  • Brucella species are intrinsically resistant to:

    • β-lactam antibiotics (Penicillins, Cephalosporins)

    • Macrolides

  • Reasons:

    • Poor intracellular penetration

    • Low affinity for penicillin-binding proteins

    • β-lactamase production (low-level)


Acquired Resistance

  • True acquired resistance is uncommon

  • Occurs mainly due to:

    • Inadequate therapy

    • Poor compliance

    • Monotherapy

  • Reported resistance:

    • Rifampicin resistance (mutations in rpoB)

    • Fluoroquinolone resistance (rare)


Recommended Combination Therapy (WHO)

Clinical Situation Regimen
Uncomplicated brucellosis Doxycycline + Rifampicin (6 weeks)
Severe disease Doxycycline + Streptomycin
Neurobrucellosis Doxycycline + Rifampicin + TMP-SMX
Pregnancy / Children Rifampicin + TMP-SMX

Antibiotic Susceptibility Testing

  • Not routinely performed

  • Done in:

    • Treatment failure

    • Relapse

    • Epidemiological studies

  • Methods:

    • MIC determination

    • Molecular detection of resistance genes

 


Prevention


Control in Animals 

A. Animal Vaccination

  • Live attenuated vaccines used in animals:
    • B. abortusStrain S19 and RB51
    • B. melitensisRev-1
  • Vaccination reduces:
    • Animal disease
    • Human transmission

B. Test and Slaughter Policy

  • Serological screening of livestock
  • Elimination of infected animals
  • Effective in non-endemic regions

Food Safety Measures

  • Pasteurization of milk
  • Avoid consumption of:
    • Raw milk
    • Unpasteurized cheese and dairy products
  • Proper cooking of meat

Occupational Protection

High-Risk Groups

  • Farmers
  • Veterinarians
  • Abattoir workers
  • Laboratory personnel

Preventive Measures

  • Use of:
    • Gloves
    • Masks
    • Protective clothing
  • Proper handling and disposal of animal products
  • Education and training

Laboratory Safety 

  • Brucella is a common laboratory-acquired infection
  • Requires:
    • Biosafety Level-3 (BSL-3) practices
  • Avoid aerosol generation
  • Use biosafety cabinets

Human Vaccination

  • No effective human vaccine available
  • Past trials discontinued due to:
    • Toxicity
    • Poor efficacy

Chemoprophylaxis

  • Not routinely recommended
  • May be considered after:
    • High-risk laboratory exposure
  • Drugs used:
    • Doxycycline + Rifampicin (short course)

Surveillance and Public Health Measures

  • Notification of cases
  • Monitoring of animal and human disease
  • Control of animal movement
  • Health education in endemic areas
  • Live attenuated vaccines used in animals:
    • B. abortusStrain S19 and RB51
    • B. melitensisRev-1
  • Vaccination reduces:
    • Animal disease
    • Human transmission

 


MCQs


1. Brucella species belong to which family?

A. Enterobacteriaceae
B. Brucellaceae
C. Pasteurellaceae
D. Neisseriaceae

Answer: B


2. Morphology of Brucella is best described as:

A. Gram-positive bacilli
B. Gram-negative cocci
C. Gram-negative coccobacilli
D. Acid-fast bacilli

Answer: C


3. Most virulent Brucella species for humans is:

A. B. abortus
B. B. suis
C. B. canis
D. B. melitensis

Answer: D


4. Brucella organisms are:

A. Obligate intracellular anaerobes
B. Facultative intracellular aerobes
C. Facultative anaerobes
D. Obligate anaerobes

Answer: B


5. Brucella species are best described as:

A. Highly invasive extracellular bacteria
B. Toxin-producing pathogens
C. Facultative intracellular pathogens
D. Obligate intracellular pathogens

Answer: C


6. Most common mode of transmission of brucellosis is:

A. Vector borne
B. Inhalation
C. Direct contact only
D. Ingestion of unpasteurized dairy products

Answer: D


7. Brucella is weakly acid-fast due to:

A. Mycolic acid
B. Lipoarabinomannan
C. Cell wall lipid content
D. Capsule

Answer: C


8. Best specimen for diagnosis of brucellosis is:

A. Urine
B. Blood
C. Throat swab
D. Stool

Answer: B


9. Highest yield culture specimen in brucellosis is:

A. Blood
B. CSF
C. Bone marrow
D. Synovial fluid

Answer: C


10. Culture medium of choice for blood culture in brucellosis is:

A. MacConkey agar
B. Blood agar
C. Lowenstein-Jensen medium
D. Castaneda biphasic medium

Answer: D


11. Brucella species require which condition for optimal growth?

A. Anaerobic
B. Microaerophilic
C. Aerobic
D. Alkaline

Answer: C


12. Which Brucella species requires CO₂ for primary isolation?

A. B. melitensis
B. B. abortus
C. B. suis
D. B. canis

Answer: B


13. Brucella colonies on blood agar are:

A. Large, hemolytic
B. Mucoid and pigmented
C. Small, smooth, non-hemolytic
D. Dry and wrinkled

Answer: C


14. Most characteristic biochemical test for Brucella is:

A. Oxidase negativity
B. Slow urease reaction
C. Rapid urease positivity
D. Sugar fermentation

Answer: C


15. Brucella species are oxidase:

A. Negative
B. Weakly positive
C. Variable
D. Positive

Answer: D


16. H₂S production is seen in:

A. B. melitensis
B. B. canis
C. B. abortus
D. All species

Answer: C


17. Brucella does NOT ferment:

A. Glucose
B. Lactose
C. Sucrose
D. All of the above

Answer: D


18. Main virulence factor of Brucella is:

A. Exotoxin
B. Capsule
C. Intracellular survival ability
D. Hemolysin

Answer: C


19. Brucella survives intracellularly by inhibiting:

A. Phagocytosis
B. Complement activation
C. Phagolysosome fusion
D. Antibody production

Answer: C


20. Type of immunity important in brucellosis is:

A. Humoral immunity
B. Complement mediated
C. Cell-mediated immunity
D. Innate immunity only

Answer: C


21. Characteristic fever pattern in brucellosis is:

A. Continuous fever
B. Step-ladder fever
C. Undulating fever
D. Relapsing fever

Answer: C


22. Most common system involved in brucellosis is:

A. Respiratory
B. Musculoskeletal
C. Gastrointestinal
D. Skin

Answer: B


23. Most common cause of death in brucellosis is:

A. Neurobrucellosis
B. Hepatitis
C. Endocarditis
D. Septic shock

Answer: C


24. Screening test for brucellosis is:

A. ELISA
B. PCR
C. Rose Bengal test
D. SAT

Answer: C


25. Diagnostic titer in Standard Agglutination Test is:

A. ≥1:40
B. ≥1:80
C. ≥1:160
D. ≥1:320

Answer: C


26. 2-Mercaptoethanol test detects mainly:

A. IgM
B. IgA
C. IgE
D. IgG

Answer: D


27. Best test for chronic brucellosis is:

A. Blood culture
B. Rose Bengal test
C. ELISA
D. Weil-Felix test

Answer: C


28. Gold standard for diagnosis of brucellosis is:

A. Serology
B. Culture
C. PCR
D. ELISA

Answer: B


29. Brucella is a common cause of:

A. Hospital-acquired infection
B. Laboratory-acquired infection
C. Vector-borne disease
D. Nosocomial pneumonia

Answer: B


30. Biosafety level required for Brucella handling is:

A. BSL-1
B. BSL-2
C. BSL-3
D. BSL-4

Answer: C


31. Drug of choice for brucellosis is:

A. Penicillin
B. Doxycycline
C. Ciprofloxacin
D. Azithromycin

Answer: B


32. Recommended treatment for uncomplicated brucellosis is:

A. Doxycycline alone
B. Rifampicin alone
C. Doxycycline + Rifampicin
D. TMP-SMX alone

Answer: C


33. Duration of treatment in brucellosis is usually:

A. 1 week
B. 2 weeks
C. 3 weeks
D. 6 weeks

Answer: D


34. Brucella shows intrinsic resistance to:

A. Tetracyclines
B. Rifampicin
C. Aminoglycosides
D. β-lactam antibiotics

Answer: D


35. Relapse in brucellosis occurs due to:

A. Toxin production
B. Antigenic variation
C. Intracellular persistence
D. Spore formation

Answer: C


36. Human vaccine against brucellosis is:

A. Available
B. Under trial
C. Live attenuated
D. Not available

Answer: D


37. Animal vaccine used against B. abortus is:

A. Rev-1
B. RB51
C. BCG
D. S19 only

Answer: B


38. Vaccine used against B. melitensis is:

A. S19
B. RB51
C. Rev-1
D. BCG

Answer: C


39. Most effective preventive measure for brucellosis is:

A. Antibiotic prophylaxis
B. Human vaccination
C. Animal vaccination
D. Isolation of patients

Answer: C


40. Pasteurization prevents brucellosis by:

A. Killing spores
B. Killing vegetative bacteria
C. Neutralizing toxins
D. Preventing fermentation

Answer: B


41. Brucella LPS is best described as:

A. Highly endotoxic
B. Weakly endotoxic
C. Neurotoxic
D. Cytolytic

Answer: B


42. Brucella canis shows which colony type?

A. Smooth
B. Mucoid
C. Rough
D. Hemolytic

Answer: C


43. Brucella infection mainly involves which system?

A. Reticuloendothelial system
B. Respiratory system
C. Gastrointestinal tract
D. Skin

Answer: A


44. Brucella species are non-motile due to absence of:

A. Pili
B. Capsule
C. Flagella
D. Fimbriae

Answer: C


45. Which test differentiates IgM from IgG antibodies?

A. Rose Bengal test
B. SAT
C. 2-ME test
D. PCR

Answer: C


46. Most common occupational group affected by brucellosis is:

A. Teachers
B. Healthcare workers
C. Veterinarians
D. Office workers

Answer: C


47. Brucellosis is also known as:

A. Enteric fever
B. Malta fever
C. Dengue fever
D. Q fever

Answer: B


48. Brucella species are killed by:

A. Cold storage
B. Pasteurization
C. Salting
D. Freezing

Answer: B


49. Reason for prolonged therapy in brucellosis is:

A. Spore formation
B. Toxin production
C. Intracellular survival
D. Capsule formation

Answer: C


50. Humans act as which type of host in brucellosis?

A. Definitive host
B. Intermediate host
C. Reservoir host
D. Dead-end host

Answer: D